Aptinyx Competitors, Revenue, Alternatives and Pricing

Claim your profile


Chicago, IL USA
Total Funding:$170M
Lead Investor(s):Bain Capital Life Sciences

Estimated Revenue & Financials

  • Aptinyx's estimated annual revenue is currently $6.7M per year.(?)
  • Aptinyx received $70.0M in venture funding in December 2017.
  • Aptinyx's estimated revenue per employee is $181,622
  • Aptinyx's total funding is $170M.

Employee Data

  • Aptinyx has 37 Employees.(?)
  • Aptinyx grew their employee count by -14% last year.
  • Aptinyx currently has 1 job openings.

Welcome to our company page and thank you for your interest in Aptinyx Inc. Aptinyx is a biopharmaceutical company discovering and developing innovative therapies for challenging disorders of the brain and nervous system. Aptinyx has a proven platform for discovering proprietary compounds that work through a novel mechanism: modulation of the NMDA receptor to enhance pathways involved with nerve cell communication. Our goal is to rapidly advance our most promising drug candidates into clinical development for indications with high unmet medical need. At Aptinyx, we remain committed and responsive to our employees. We offer an engaging work environment, challenging work assignments, and competitive compensation and benefits. If you are interested in learning more, please visit our website at www.aptinyx.com.